Thalassemia is a type of hemoglobinopathy due to the defect of globin chains, which can be divided into 2 types of alpha and beta, depending on the type of globulin involved (
1). The cause of beta thalassemia is the reduction or nonproduction of beta-globin chain, which leads to the formation of abnormal and fragile red cells that can easily lead to hemolysis and cause chronic anemia (
2). This is a monogenic disorder inherited as autosomal recessive disease from parents. Thalassemia is the most common genetic disease in humans and has a high prevalence in the Mediterranean, Middle East, and South-East Asia regions. Beta thalassemia consists of 3 major groups: thalassemia major, intermedia thalassemia, and thalassemia minor (
3). In 2013, WHO statistics showed that there are 30 000 patients with thalassemia major in Iran. With this number of patients, Iran is ranked first in the proportion of thalassemia patients to the total population in the world (
4,
5). The highest incidence of β-thalassemia in the Caspian Sea and the Persian Gulf has been reported by more than 10%. The prevalence of this disorder in other areas is 4% to 8% (
6) and 0.6% in Khorasan Razavi province (
7). Chronic diseases make life difficult for patients and reduce their quality of life (
8). Thalassemia, like any other chronic diseases, affects the various aspects of a person’s life, and despite repeated medical treatment, the symptoms and clinical symptoms cause many physical and psychological problems for the patients, which can have an adverse effect on their quality of life (
9).
Quality of life is a range of human objective needs that is achieved in relation to the personal and group understanding of people about the feeling of well-being (
10). Quality of life is considered as an important indicator, and the effectiveness of many health interventions is evaluated by this index (
11). Thalassemia patients have severe psychiatric and social problems compared to healthy individuals, and thus medical treatment should be combined with emotional, psychological, and social support to improve the quality of life of these patients and prevent irreversible complications (
12). Results of Hadi et al. study in Shiraz showed that thalassemia major severely affects patients’ quality of life. Adolescent patients received lower scores in physical health (including role limitation due to physical problems, physical functioning, physical pain, and general health). In other words, these patients suffer from more physical problems. In general health, patients in this study stated that they are more likely than others to have the disease and wait for their health to worsen and experience more physical pain (
10). Studies conducted by Clarke et al. in England and Torcharus et al. in Thailand also showed similar results about the lower quality of life of children and adolescents with thalassemia compared to the control group (
13,
14). According the above- mentioned explanations, one of the goals of caregivers should be improving the quality of life of these patients. One of the ways to achieve this goal is to educate thalassemia patients to improve their quality of life and help them deal with the effects and complications of the disease. On the other hand, training the points of caregiving for thalassemia patients is one of the main components of the treatment process to improve self-care behaviors and encourage the patients to participate in training courses (
15). Education plays a central role in managing chronic diseases and is an essential component of thalassemia control (
16). The effect of patient education in various researches has been confirmed, so that the patient’s lack of sufficient knowledge of the care orders lead to patients failing to follow the medical orders (
17). For example, Ghazanfaris study shows that the level of knowledge of parents of thalassemia patients is low and they need a great deal of training (
18). Lee also concluded that providing regular education to patients and caregivers is highly important in improving the patients’ quality of life and encouraging them to continue the treatment (
19). In addition, studies have shown that intervention in patient and education groups increased their understanding of the disease (
20,
21). Accordingly, healthcare providers, such as physicians and nurses, have found that the physical aspects of the patient cannot be only focused on treating individuals with thalassemia, but also various aspects of life of patients should be considered to help them live a normal life, while one of the important interventions is providing counseling and rehabilitation programs. Therefore, the health professionals, including nurses, by providing educational and counseling programs can help the patients deal with their chronic diseases, such as thalassemia. Many studies have been conducted on the symptoms and complications and also the prevalence of thalassemia, but so far in Iran, there has been no research on the effectiveness of educational counseling on the quality of life in patients with thalassemia. Therefore, the present study, conducted in 2016, aimed at determining the effect of an educational counseling program on the quality of life of thalassemia patients, improving their quality of life, enhancing caregiving capacity by educating patients, and increasing their awareness of the disease, symptoms, and complications.